A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres
- PMID: 30970015
- PMCID: PMC6457483
- DOI: 10.1371/journal.pone.0214361
A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres
Erratum in
-
Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres.PLoS One. 2019 Apr 25;14(4):e0216315. doi: 10.1371/journal.pone.0216315. eCollection 2019. PLoS One. 2019. PMID: 31022288 Free PMC article.
Abstract
Quantifying the value of investment in medical research can inform decision-making on the prioritisation of research programmes. Existing methodologies to estimate the rate of return of medical research are inappropriate for early-phase translational research due to censoring of health benefits and time lags. A strategy to improve the process of translational research for patient benefit has been initiated as part of the UK National Institute for Health Research (NIHR) investment in Biomedical Research Centres (BRCs) in England. By providing a platform for partnership between universities, NHS trusts and industry, successful BRCs should reduce time lags within translational research whilst also providing an impetus for local economic growth through industry collaboration. We present a novel contribution in the assessment of early-phase biomedical research by estimating the impact of the Oxford Biomedical Research Centre (OxBRC) on income and job creation following the initial NIHR investment. We adopt a macroeconomic assessment approach using Input-Output Analysis to estimate the value of medical research in terms of income and job creation during the early pathway towards translational biomedical research. Inter-industry linkages are assessed by building a model economy for the South East England region to estimate the return on investment of the OxBRC. The results from the input-output model estimate that the return on investment in biomedical research within the OxBRC is 46%. Each £1 invested in the OxBRC generates an additional £0.46 through income and job creation alone. Multiplicative employment effects following a marginal investment in the OxBRC of £98m during the period 2007-2017 result in an estimated additional 196 full time equivalent positions being created within the local economy on top of direct employment within OxBRC. Results from input-output analyses can be used to inform the prioritisation of biomedical research programmes when compared against national minimum thresholds of investment.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes.Health Res Policy Syst. 2018 Jan 10;16(1):1. doi: 10.1186/s12961-017-0276-7. Health Res Policy Syst. 2018. PMID: 29316935 Free PMC article.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess. 2024 Oct;28(73):1-230. doi: 10.3310/YAPL9347. Health Technol Assess. 2024. PMID: 39487661 Free PMC article.
-
Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom.BMC Med. 2016 Feb 24;14:32. doi: 10.1186/s12916-016-0564-z. BMC Med. 2016. PMID: 26908129 Free PMC article.
-
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess. 2024 Jun;28(28):1-238. doi: 10.3310/YGWR4511. Health Technol Assess. 2024. PMID: 38938145 Free PMC article.
-
Maximising value from a United Kingdom Biomedical Research Centre: study protocol.Health Res Policy Syst. 2017 Aug 14;15(1):70. doi: 10.1186/s12961-017-0237-1. Health Res Policy Syst. 2017. PMID: 28806989 Free PMC article.
Cited by
-
How do organisations implement research impact assessment (RIA) principles and good practice? A narrative review and exploratory study of four international research funding and administrative organisations.Health Res Policy Syst. 2020 Jan 20;18(1):6. doi: 10.1186/s12961-019-0515-1. Health Res Policy Syst. 2020. PMID: 31959198 Free PMC article.
-
Lessons from the pandemic on the value of research infrastructure.Health Res Policy Syst. 2021 Apr 1;19(1):54. doi: 10.1186/s12961-021-00704-2. Health Res Policy Syst. 2021. PMID: 33794906 Free PMC article.
-
Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres.PLoS One. 2019 Apr 25;14(4):e0216315. doi: 10.1371/journal.pone.0216315. eCollection 2019. PLoS One. 2019. PMID: 31022288 Free PMC article.
-
Assessing the quality of studies funded by the Israel National Institute for Health Policy Research, 2010-2020.Isr J Health Policy Res. 2025 Mar 5;14(1):10. doi: 10.1186/s13584-025-00672-w. Isr J Health Policy Res. 2025. PMID: 40038781 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources